 Bionanotechnology is concerned with the interactions and integration of nanomaterials and devices with biological systems (at the molecular, cellular, organism and population levels) and their exploitation in products and processes. One area of exploitation is in advanced healthcare provision and in this regard it forms the foundations of nanomedicine. In this meeting the applications of nanoscale science to drug discovery, novel therapeutics, diagnostics, regenerative medicine and drug delivery will be presented.
Professor Tony Cass, Institute of Biomedical Engineering, Imperial College London
The deadline for abstract submissions is February 10th 2008
Abstract guidelines can be found at http://www.euroscicon.com/absguidlines.html
The deadline for early registration is March 20th 2008
|
